Evidence map›Paper›PMID 25274585›Full record

ReviewNeurosciences (Riyadh, Saudi Arabia)2014

Retinal phototransduction.

Gurdeep S Mannu

Abstract readReview
In one paragraph

Review in Neurosciences (Riyadh, Saudi Arabia), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Review
  3. Gene Therapy for Achromatopsia.International journal of molecular sciences · 2024
    Review
  4. Transcriptome Profiling of Etridiazole-Exposed Zebrafish (International journal of molecular sciences · 2023
    Article
  5. Ginsenoside Re Mitigates Photooxidative Stress-Mediated Photoreceptor Degeneration and Retinal Inflammation.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2023
    Article
  6. Article
  7. Review
  8. Article
  9. Tissue Engineering Strategies for Retina Regeneration.Applied sciences (Basel, Switzerland) · 2021
    Article
  10. A Ketogenic & Low-Protein Diet Slows Retinal Degeneration in rd10 Mice.Translational vision science & technology · 2020
    Article
  11. Nutrition research and practice · 2020
    Article
  12. Article
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Gurdeep S MannuAcademic Medicine Department, Norfolk and Norwich University Hospital, Colney Lane, Norwich, Norfolk NR4 7UY, United Kingdom. Tel. +44 (1603) 286286. Fax. +44 (1603) 287211. E-mail: Gurdeepmannu@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vision is perhaps the most important of all our senses, and gives us an immense amount of information regarding the outside world. The initial format in which this information reaches the retina are photons; particles of energy radiation of a given wavelength emitted or reflected from our surroundings. The brain itself however, perceives information in electrical signals via action potentials and changes in electrochemical gradients. The processes involved in the transduction of photons into electrical potentials will be the focus of this article. This review article summarizes the recent advances in understanding these complex pathways and provides an overview of the main molecules involved in the neurobiology of vision.

Indexed as

Action PotentialsAnimalsCalcium SignalingCyclic GMPG-Protein-Coupled Receptor Kinase 1HumansOpsinsPhotonsProtein ConformationRecoverinRetinaRetinaldehydeRetinal PigmentsRetinal Rod Photoreceptor CellsSecond Messenger SystemsVision, OcularCyclic GMPG-Protein-Coupled Receptor Kinase 1OpsinsRecoverinRetinaldehydeRetinal Pigments

Identifiers

PMID25274585
PMCPMC4727664

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.